Paragon Bioservices Hires New VP of Quality
BALTIMORE, Sept. 30, 2015 /PRNewswire/ — Paragon Bioservices, Inc., a contract development & manufacturing organization (CDMO), announced today the appointment of Carolyn Phillips to the position of Vice President, Quality. Ms. Phillips will have oversight responsibility for all aspects of quality at Paragon directing quality associates and working closely with customers to ensure the highest quality standards.
As a Microbiologist, Ms. Phillips comes to Paragon with a wealth of knowledge and over 25 years of industry experience at leading companies such as BioReliance, Human Genome Sciences and most recently at Genzyme (a Sanofi Company). At Genzyme, she led four large quality control groups that included microbiology, chemistry, validation and operations. She has comprehensive knowledge of Quality and FDA guidelines and has demonstrated proven success in the areas of Quality Control, Validation, Compliance, remediation and implementation of Quality Systems and Contamination Control. Since 2007, she has served as a delegate to an ISO Working Group responsible for establishing standards for biocontamination control in cleanrooms. Ms. Phillips earned her B.S. in Biology (Magna Cum Laude with Distinction) from Georgia State University.
“Quality is of critical importance to Paragon and our customers,” said Marco Chacon, Paragon’s Chief Executive officer. “We are excited to welcome Carolyn to our leadership team and have great confidence that she will ensure the continuation of Paragon’s strong commitment to quality and in helping our clients achieve their goals in a timely manner.”
About Paragon Bioservices, Inc.
Founded in 1990, Paragon Bioservices is a contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of biopharmaceuticals—including the production and purification of monoclonal antibodies, recombinant proteins, viral vectors and vaccines. The company provides research services, process development, and cGMP manufacturing. Paragon’s cGMP space includes microbial and mammalian suites, fill-finish and fully-segregated virus facilities.
Dr. Philip Wills
PH: (410) 975-4050